SkinBioTherapeutics faces April trading suspension until review ends
(Alliance News) - SkinBioTherapeutics PLC shares slid on Friday after the firm said it will be suspended from trading on the AIM market at the start of April until the review of its former chief executive's conduct concludes. Read More